Navigation Links
Angiotech announces positive results from Bio-Seal(TM) clinical study
Date:3/9/2009

VANCOUVER, March 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced positive clinical study results for its Bio-Seal(TM) Lung Biopsy Tract Plug System at the Society of Interventional Radiologists Annual Scientific Meeting in San Diego, CA. The trial assessed the safety and efficacy of Bio-Seal in patients undergoing lung biopsy procedures and demonstrated a statistically significant clinical benefit in the group receiving BioSeal.

"We are extremely pleased that the Bio-Seal treatment arm hit the primary end point of clinical success," said Dr. William Hunter, President and CEO of Angiotech. "These results indicate that Bio-Seal improves the existing technology used to diagnose lung cancer by significantly reducing the rates of pneumothorax."

The purpose of this clinical study was to assess the safety and efficacy of an expanding hydrogel plug in reducing pneumothorax rates associated with CT-guided lung biopsy. The prospective, randomized, controlled clinical study enrolled and randomized 339 investigational patients at 15 different investigational sites. Inspiratory upright chest x-rays were performed at 30 to 60 minutes, 24 hours and 30 days after treatment. The Bio-Seal treatment arm hit the primary end point of clinical success, absence of pneumothorax at each time period. Based on the per-protocol population, clinical success rate was 85% using Bio-Seal and 69% in the control group. This difference was statistically significant (p=0.002). Although not powered for statistical analysis, positive trends were also observed for Bio-Seal subjects as compared to the control group in various secondary endpoints, including fewer Bio-Seal subjects admitted to the hospital for pneumothoraces (9.4% vs. 13.6%), fewer chest tubes placements in Bio-Seal patients (3.5% vs. 10.7%), and fewer additional chest x-r
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Until recently, pets suffering from arthritic ailments ... their pain. Pill therapies are costly, can be harmful ... , The procedure uses adult (not embryonic) animal ... regenerative healing power. MediVet's equipment enable veterinarians to remove ... stem cells, then activate and inject the cells into ...
(Date:9/11/2014)... 11, 2014  Ikonopedia will showcase its new ... imaging reporting modules here at the Intensive Breast ... Ikonopedia,s revolutionary suite of report generation software tools ... they look like rather than what they are ... reporting efficiency, and optimize facility operations.  ...
(Date:9/11/2014)... Florida (PRWEB) September 11, 2014 Central ... to announce his partnerships with several Brevard County animal ... Dr. Christiansen has been working in the area since ... small animals since 2008, and is happy to now ... the years Dr. Christiansen has used stem cell therapy ...
(Date:9/10/2014)... Jersey (PRWEB) September 11, 2014 ... its annual Innovations in Dermatological Sciences conference Oct. ... focus on how the university, industry and government ... into clinical use. , This conference is unique ... with cross-sector collaboration, to share their successes, best-practices, ...
Breaking Biology Technology:MediVet America Secures Exclusive Worldwide License with Nanofiber Veterinary 2Ikonopedia Showcases New MQSA Management System and Reporting Modules at Intensive Breast Ultrasound Meeting 2Ikonopedia Showcases New MQSA Management System and Reporting Modules at Intensive Breast Ultrasound Meeting 3Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 2Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 3Innovations in Dermatological Sciences 2014 2Innovations in Dermatological Sciences 2014 3
... BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced that ... will present,a corporate update at the JMP Healthcare Focus ... 10:00 a.m. Eastern Time., A link to a ... accessed on,the BioCryst Web site http://www.biocryst.com . The ...
... Second FDA Cleared Diagnostic Test in 2008; Test, Improves Time-to-Result by ... ... Methods, SUNNYVALE, Calif., Oct. 1 Cepheid (Nasdaq:,CPHD) today announced ... market its Xpert(TM) MRSA/SA Blood Culture (BC),test, which runs on the GeneXpert(R) ...
... Limited,(LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,announces ... General,Meeting on September 24, 2008, the Company has changed ... Shire plc,s ticker symbols on the London Stock Exchange ... shares and American Depositary,Shares will remain unchanged., Notes ...
Cached Biology Technology:BioCryst to Present at the JMP Healthcare Focus Conference 2BioCryst to Present at the JMP Healthcare Focus Conference 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 4Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 5
(Date:9/11/2014)... associate professor of mechanical engineering at Worcester ... the university,s Integrative Materials Design Center (iMdc), ... the National Science Foundation (NSF) to support ... manufacture metal-ceramic composites, which can be used ... efficient, while significantly increasing their performance. , ...
(Date:9/11/2014)... , Sept. 11, 2014 /PRNewswire-iReach/ -- Today at the ... a patient portal that puts genome sequencing results at ... useful and actionable. The $1000 was announced ... many to be the tipping point towards widespread adoption ... 6 billion letters and 4 million variants per human ...
(Date:9/11/2014)... has estimated the total mass of oil that reached the ... Deepwater Horizon blowout. It,s the first time such an estimate ... issue of Environmental Science and Technology . , ... Gulf shoreline in 2010. This finding will help officials determine ... harm to the ecosystem. , The study was conducted by ...
Breaking Biology News(10 mins):NSF funds new method for making materials that can make lighter, more efficient vehicles 2NSF funds new method for making materials that can make lighter, more efficient vehicles 3Tute Genomics Launches MyGene Portal for Genome-guided Medicine 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 3NJIT researchers working to safeguard the shoreline 2
... a person this is the greatest of pleasures. But, in ... beer as it is among the most energy-intensive foodstuffs during ... working hard to improve the energy balance of the amber ... would allow energy savings of up to 20% during brewing. ...
... pollution, or smog, is a highly reactive, colorless gas ... pollution is most often associated with outdoor air, the ... Ozone can be released by ordinary copy machines, laser ... all of which contribute to increased indoor ozone levels. ...
... Researchers in Australia are developing diversionary tactics to ... those responsible for major gut infections, such as cholera, ... to complex sugar receptors displayed on the surface of ... Society for General Microbiology,s meeting at Heriot-Watt University, Edinburgh, ...
Cached Biology News:Environmentally 'green' beer: Munich brewing engineers research energy savings 2Environmentally 'green' beer: Munich brewing engineers research energy savings 3Houseplants cut indoor ozone 2Designing probiotics that ambush gut pathogens 2
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
...
Biology Products: